Saturday, March 11, 2017 1:29:03 PM
Read this: A number of large investors have recently added to or reduced their stakes in the stock. State Treasurer State of Michigan increased its stake in Evoke Pharma by 460.0% in the third quarter. State Treasurer State of Michigan now owns 140,000 shares of the specialty pharmaceutical company’s stock worth $316,000 after buying an additional 115,000 shares during the last quarter. Vanguard Group Inc. increased its stake in Evoke Pharma by 5.0% in the second quarter. Vanguard Group Inc. now owns 62,381 shares of the specialty pharmaceutical company’s stock worth $427,000 after buying an additional 2,947 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its stake in Evoke Pharma by 2.0% in the second quarter. Bank of New York Mellon Corp now owns 23,679 shares of the specialty pharmaceutical company’s stock worth $162,000 after buying an additional 464 shares during the last quarter. 5.13% of the stock is currently owned by institutional investors.
What does it indicate all the big investors are buy and holding becouse they know what this is going be when FDA approve the drug for marking.
Recent EVOK News
- Form SC 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 09/20/2024 11:28:39 PM
- Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments • GlobeNewswire Inc. • 09/19/2024 06:20:38 PM
- Evoke Pharma to Participate in Gastroenterology and Hepatology Advanced Practice Providers (GHAPP) Annual Conference • GlobeNewswire Inc. • 09/09/2024 12:30:08 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/09/2024 04:15:04 AM
- Evoke Pharma to Present at H.C. Wainwright’s 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/04/2024 01:20:55 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/29/2024 08:16:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 11:00:08 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/13/2024 09:01:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 12:20:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 12:15:18 PM
- Evoke Pharma, Inc. Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/13/2024 12:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 09:11:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:51:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:48:45 PM
- Evoke Pharma, Inc. Supports Gastroparesis Awareness Month • GlobeNewswire Inc. • 08/08/2024 12:30:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:00:09 AM
- Evoke Pharma, Inc. Announces Reverse Stock Split • GlobeNewswire Inc. • 07/30/2024 12:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 11:01:20 AM
- Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI • GlobeNewswire Inc. • 06/17/2024 12:30:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 12:00:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 09:02:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:56:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:53:59 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM